The European Commission presents the European Care Strategy to ensure quality, affordable and accessible care services across the European Union and improve the situation for both care receivers and the people caring for them, professionally or informally. The Strategy is accompanied by two Recommendations for Member States on the revision of the Barcelona targets on […]
Read More
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns. The EU has recently extended its arsenal with two new updated vaccines, Comirnaty […]
Read MoreHealth Union: HERA additional vaccine doses monkeypox
HERA, the Commission’s Health Emergency Preparedness and Response Authority, has secured an additional 170,920 doses of Bavarian Nordic’s 3rd generation vaccine to respond to the ongoing monkeypox outbreak and to meet the more immediate needs. This brings the total number of doses directly purchased by the EU to 334,540 for Member States. These additional doses will be available […]
Read More
COVID-19 evolution in America
This news item shows updated data, obtained from Johns Hopkins University, concerning the incidence of diagnosed cases and deaths from the COVID-19 virus in America. As of September 06, 2022, a total of 196,578 daily cases of COVID-19 have been diagnosed in the Americas in the last 7 days, with the countries with the highest […]
Read More
Three steps forward towards an equal sharing of unpaid care
One-in-three people across the EU are unpaid informal carers for family members or friends in need due to health problems and/or disability. And that’s just one of the key findings from EIGE’s annual Gender Equality Index report, which this year focuses on the COVID-19 pandemic and care – published this October 2022. “This is the kind […]
Read More
Commission rallies Member States to prepare for autumn and winter
The Commission is proposing concrete measures to avoid a surge of COVID-19 cases in the upcoming autumn and winter season. The Commission is urging Member States to put the necessary strategies and structures in place, including for COVID-19 vaccination and surveillance, to respond to future outbreaks in a fast and sustained manner. The main aim of […]
Read More
First adapted COVID-19 booster vaccines recommended for approval in the EU
EMA’s human medicines committee (CHMP) has recommended authorising two vaccines adapted to provide broader protection against COVID-19. Comirnaty Original/Omicron BA.1 and Spikevax Bivalent Original/Omicron BA.1 are for use in people aged 12 years and above who have received at least primary vaccination against COVID-19. These vaccines are adapted versions of the original vaccines Comirnaty (Pfizer/BioNTech) […]
Read More
Commission decides to register new European Citizens’ Initiative on tobacco
The Commission decided to register a European Citizens’ Initiative (ECI) entitled ‘Call to achieve a tobacco-free environment and the first European tobacco-free generation by 2030′. The organisers of the initiative call on the Commission to propose legislation to save new generations from falling into tobacco addiction, to act against related environmental dangers and against smoking. […]
Read More
EMA advises on intradermal use of Imvanex / Jynneos against monkeypox
The European Medicines Agency (EMA) has advised on intradermal use of monkeypox vaccine. EMA’s Emergency Task Force (ETF) has reviewed data showing that people who receive the monkeypox vaccine as an intradermal injection (injection into the skin) produce similar levels of antibodies to those who receive it as a subcutaneous injection (injection under the skin). As only […]
Read More